A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus

This publication has 20 references indexed in Scilit:

• A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice
  Journal of Virology, 2003
• Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
  The American Journal of Pathology, 2003
• Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation
  The Journal of Infectious Diseases, 2003
• The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
  Journal of Virology, 2003
• IKKε and TBK1 are essential components of the IRF3 signaling pathway
  Nature Immunology, 2003
• The interferon antiviral response: from viral invasion to evasion
  Current Opinion in Infectious Diseases, 2002
• Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in Vitro
  Virology, 2001
• Inhibition of Interferon-Mediated Antiviral Responses by Influenza A Viruses and Other Negative-Strand RNA Viruses
  Virology, 2001
• The Ebola virus VP35 protein functions as a type I IFN antagonist
  Proceedings of the National Academy of Sciences, 2000
• The VP35 and VP40 proteins of filoviruses
  FEBS Letters, 1993